Skip to search formSkip to main contentSkip to account menu

Candida albicans infection

Known as: albicans candida infections 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Background. The ability of epithelial cells (ECs) to discriminate between commensal and pathogenic microbes is essential for… 
Review
2006
Review
2006
The different manifestations of Candida albicans infection are dictated by an underlying defect in the immune response of the… 
Highly Cited
1998
Highly Cited
1998
The effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on acute disseminated Candida albicans infection in… 
Highly Cited
1990
Highly Cited
1990
A water‐soluble oligosaccharide, N‐acetylchitohexaose (NACOS‐6), was able to enhance the protective effect against Candida… 
Highly Cited
1988
Highly Cited
1988
Natural and synthetic immunomodulators that increase nonspecific resistance to infection are also known to induce interleukin 1… 
Highly Cited
1983
Highly Cited
1983
Mice receiving a single injection of cyclophosphamide (150 mg/kg) 1 to 6 days before inoculation with viable Candida albicans… 
1981
1981
Mice immunized with viable C. albicans cells demonstrated a high incidence of cell‐mediated and a low incidence of humoral immune… 
Highly Cited
1975
Highly Cited
1975
An immunosuppressed mouse model was devised to test the effects of immunopotentiators on the prevention of bacterial and fungal… 
Highly Cited
1974
Highly Cited
1974
The effects of administration of 5-fluorocytosine alone or in combination with amphotericin B on the course of fatal Candida… 
Review
1953
Review
1953
In reporting the work of a penicillin therapeutic research unit, Christie and Garrod (1944) cited a case of actinomycosis treated…